Cargando…
A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy
BACKGROUND: As an efficient tumor immunotherapy, PD-1 antibody has been gradually used in clinical tumor treatment, but the low response rate and excessive immune response limit its extensive application. RESULTS: Herein, a therapeutic regime for the reinvigoration and activation of the tumor immune...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686283/ https://www.ncbi.nlm.nih.gov/pubmed/34930285 http://dx.doi.org/10.1186/s12951-021-01193-9 |